BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
Rhea-AI Summary
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that its Executive Vice President and Chief Financial Officer, Brian Mueller, will be presenting at the 22nd Annual Morgan Stanley Global Healthcare Conference. The presentation is scheduled for Thursday, September 5, 2024, at 7:45 AM PT / 10:45 AM ET in New York, NY.
Investors and interested parties can access a live audio webcast of the presentation through the company's website at https://investors.biomarin.com/. For those unable to attend or listen live, an archived version of the remarks will be available on the company's website for a time following the conference.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BMRN gained 1.16%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | 650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-22nd-annual-morgan-stanley-global-healthcare-conference-on-thursday-september-5-at-745-am-pt--1045-am-et-in-new-york-ny-302233312.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When is BioMarin (BMRN) presenting at the Morgan Stanley Global Healthcare Conference?
Who will be representing BioMarin (BMRN) at the Morgan Stanley Global Healthcare Conference?
How can I listen to BioMarin's (BMRN) presentation at the Morgan Stanley conference?
Will BioMarin's (BMRN) presentation at the Morgan Stanley conference be available after the event?
What is the full name of the conference BioMarin (BMRN) is attending in September 2024?
